{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53200"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53200","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Intermittent fasting and its potential role in treating type 2 diabetes","abstract":"Type 2 Diabetes Mellitus (T2DM) is a pervasive chronic disease, affecting millions worldwide. Caused by insulin insensitivity and decreased insulin secretion, high blood glucose levels can lead to long-term health complications such as diabetic kidney disease and neuropathy. There are various pharmacological interventions available on the market to treat T2DM, including biguanides, sulfonylureas, glinides, glucagon-like peptide-1 agonists, sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors. Through various mechanisms, these drugs help lower blood glucose levels. Intermittent fasting has been an increasingly popular approach to caloric restriction used in weight loss regimens. This thesis aims to compare the effectiveness of intermittent fasting in regulating blood glucose levels and body weight to that of the pharmacological interventions. Possessing high treatment feasibility, high compliance rates, and low risks of adverse effects were also factored into analysis. By evaluating these factors, I concluded that intermittent fasting is an effective treatment option for T2DM. I believe the combination therapy of intermittent fasting and sodium-glucose co-transport-2 inhibitors will most effectively manage blood glucose levels and body weight. Given that research on combining intermittent fasting with pharmacological interventions is limited, further research of this field is warranted to potentially improve the treatment of T2DM.","abstract_html":"Type 2 Diabetes Mellitus (T2DM) is a pervasive chronic disease, affecting millions worldwide. Caused by insulin insensitivity and decreased insulin secretion, high blood glucose levels can lead to long-term health complications such as diabetic kidney disease and neuropathy. There are various pharmacological interventions available on the market to treat T2DM, including biguanides, sulfonylureas, glinides, glucagon-like peptide-1 agonists, sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors. Through various mechanisms, these drugs help lower blood glucose levels. Intermittent fasting has been an increasingly popular approach to caloric restriction used in weight loss regimens. This thesis aims to compare the effectiveness of intermittent fasting in regulating blood glucose levels and body weight to that of the pharmacological interventions. Possessing high treatment feasibility, high compliance rates, and low risks of adverse effects were also factored into analysis. By evaluating these factors, I concluded that intermittent fasting is an effective treatment option for T2DM. I believe the combination therapy of intermittent fasting and sodium-glucose co-transport-2 inhibitors will most effectively manage blood glucose levels and body weight. Given that research on combining intermittent fasting with pharmacological interventions is limited, further research of this field is warranted to potentially improve the treatment of T2DM.","abstract_has_math":false,"creators":["Swamynathan, Rithvik"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Trinkaus-Randall, Vickery","Schonhoff, Christopher"],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T19:37:35Z","subjects":["Medicine"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0007-9372-5244"],"render_values":[{"text":"0009-0007-9372-5244","href":"https://orcid.org/0009-0007-9372-5244","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/53200","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53200","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53200","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Trinkaus-Randall, Vickery","Schonhoff, Christopher"]},{"key":"dc:creator","label":"Author","values":["Swamynathan, Rithvik"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0007-9372-5244"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-06-22T18:59:31Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-06-22T18:59:31Z"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-06-18T19:18:37Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53200"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2025"]},{"key":"dc:description.abstract","label":"Abstract","values":["Type 2 Diabetes Mellitus (T2DM) is a pervasive chronic disease, affecting millions worldwide. Caused by insulin insensitivity and decreased insulin secretion, high blood glucose levels can lead to long-term health complications such as diabetic kidney disease and neuropathy. There are various pharmacological interventions available on the market to treat T2DM, including biguanides, sulfonylureas, glinides, glucagon-like peptide-1 agonists, sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors. Through various mechanisms, these drugs help lower blood glucose levels. Intermittent fasting has been an increasingly popular approach to caloric restriction used in weight loss regimens. This thesis aims to compare the effectiveness of intermittent fasting in regulating blood glucose levels and body weight to that of the pharmacological interventions. Possessing high treatment feasibility, high compliance rates, and low risks of adverse effects were also factored into analysis. By evaluating these factors, I concluded that intermittent fasting is an effective treatment option for T2DM. I believe the combination therapy of intermittent fasting and sodium-glucose co-transport-2 inhibitors will most effectively manage blood glucose levels and body weight. Given that research on combining intermittent fasting with pharmacological interventions is limited, further research of this field is warranted to potentially improve the treatment of T2DM."]},{"key":"dc:title","label":"Title","values":["Intermittent fasting and its potential role in treating type 2 diabetes"]}]}],"canonical_facts":{"dc:contributor.advisor":["Trinkaus-Randall, Vickery","Schonhoff, Christopher"],"dc:creator":["Swamynathan, Rithvik"],"dc:date.accessioned":["2026-06-22T18:59:31Z"],"dc:date.available":["2026-06-22T18:59:31Z"],"dc:date.issued":["2025"],"dc:date.updated":["2026-06-18T19:18:37Z"],"dc:description":["2025"],"dc:description.abstract":["Type 2 Diabetes Mellitus (T2DM) is a pervasive chronic disease, affecting millions worldwide. Caused by insulin insensitivity and decreased insulin secretion, high blood glucose levels can lead to long-term health complications such as diabetic kidney disease and neuropathy. There are various pharmacological interventions available on the market to treat T2DM, including biguanides, sulfonylureas, glinides, glucagon-like peptide-1 agonists, sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors. Through various mechanisms, these drugs help lower blood glucose levels. Intermittent fasting has been an increasingly popular approach to caloric restriction used in weight loss regimens. This thesis aims to compare the effectiveness of intermittent fasting in regulating blood glucose levels and body weight to that of the pharmacological interventions. Possessing high treatment feasibility, high compliance rates, and low risks of adverse effects were also factored into analysis. By evaluating these factors, I concluded that intermittent fasting is an effective treatment option for T2DM. I believe the combination therapy of intermittent fasting and sodium-glucose co-transport-2 inhibitors will most effectively manage blood glucose levels and body weight. Given that research on combining intermittent fasting with pharmacological interventions is limited, further research of this field is warranted to potentially improve the treatment of T2DM."],"dc:identifier.orcid":["0009-0007-9372-5244"],"dc:identifier.uri":["https://hdl.handle.net/2144/53200"],"dc:language.iso":["en_US"],"dc:subject":["Medicine"],"dc:title":["Intermittent fasting and its potential role in treating type 2 diabetes"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T19:37:35Z"}